Skip to Main Content
Table 1—

Patient characteristics and clinical outcomes

Standard therapyEnhanced therapy
Patient population 44 41 
Age (years) 54.8 ± 9.6 55.0 ± 9.3 
Sex (% men) 52.3 48.8 
Duration of diabetes (years) 12.7 ± 10.0 14.8 ± 11.5 
Risk category 2 26 (59) 24 (59) 
Risk category 3 18 (41) 17 (41) 
History of amputation 1 (fifth toe amputation) 1 (second toe amputation) 
Risk category mean 2.41 ± 0.50 2.41 ± 0.50 
VPT (left foot) 33.8 ± 10.4 35.9 ± 9.1 
VPT (right foot) 35.9 ± 11.3 36.5 ± 8.6 
Elective/voluntary dropouts from the study 
Outcomes   
    Foot ulceration 7* 
    Charcot fracture 
    Total 9* 
Standard therapyEnhanced therapy
Patient population 44 41 
Age (years) 54.8 ± 9.6 55.0 ± 9.3 
Sex (% men) 52.3 48.8 
Duration of diabetes (years) 12.7 ± 10.0 14.8 ± 11.5 
Risk category 2 26 (59) 24 (59) 
Risk category 3 18 (41) 17 (41) 
History of amputation 1 (fifth toe amputation) 1 (second toe amputation) 
Risk category mean 2.41 ± 0.50 2.41 ± 0.50 
VPT (left foot) 33.8 ± 10.4 35.9 ± 9.1 
VPT (right foot) 35.9 ± 11.3 36.5 ± 8.6 
Elective/voluntary dropouts from the study 
Outcomes   
    Foot ulceration 7* 
    Charcot fracture 
    Total 9* 

Data are means ± SD or n (%).

*

P < 0.05.

Close Modal

or Create an Account

Close Modal
Close Modal